tiprankstipranks
Sab Biotherapeutics, Inc. (SABS)
:SABS
US Market
Holding SABS?
Track your performance easily

SAB Biotherapeutics (SABS) Ownership - Who Owns SAB Biotherapeutics?

133 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,104,424Insider87.81%28,203,396
5,232,304Insider56.69%18,208,418
2,857,142Insider30.96%9,942,854
766,699Insider8.31%2,668,113
394,989Insider4.28%1,374,562
276,242Institution2.99%961,322
275,203Institution2.98%957,706
57,313Insider0.62%199,449
54,850Institution0.59%190,878
48,428Insider0.52%168,529

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
275,203Institution2.98%957,706
54,850Institution0.59%190,878
3,669Institution0.04%12,768

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
232,567Institution2.52%679,096
43,675Institution0.47%127,531
15,110Institution0.16%52,583

FAQ

Who Owns Sab Biotherapeutics, Inc. (SABS)?
Currently, no data Available
What percentage of Sab Biotherapeutics, Inc. (SABS) stock is held by institutional investors?
Currently, no data Available
What percentage of Sab Biotherapeutics, Inc. (SABS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Sab Biotherapeutics, Inc. (SABS)?
Christine Hamilton owns the most shares of Sab Biotherapeutics, Inc. (SABS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis